Sutures are stitches that doctors and surgeons, use to hold skin, internal organs, blood vessels, and all other tissues of the human body together, after the injury, incision, or surgery.
North America holds the highest market share in the global dissolvable sutures market owing to the higher adoption of technologically advanced products for surgical procedures in the region, increase in the prevalence of various chronic diseases, and the development of the wound management sector.
Asia Pacific is experiencing the fastest growth for the global dissolvable sutures market owing to the increasing prevalence of cardiac diseases, rising obese pool, increasing cases of burns, and geriatric population. India and China dominate the market for dissolvable sutures in the Asia Pacific region.
In 2019, the market size of Polyglactin 910 Sutures (PGLA Sutures) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Polyglactin 910 Sutures (PGLA Sutures).
This report studies the global market size of Polyglactin 910 Sutures (PGLA Sutures), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Polyglactin 910 Sutures (PGLA Sutures) production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Medtronic
Boston Scientific
Johnson & Johnson
Smith & Nephew
B. Braun Melsungen
Demetech
Peters Surgical
Sutures India
Dolphin Sutures
Internacional Farmaceutica
Market Segment by Product Type
Uncoated PGLA Sutures
Coated PGLA Sutures
Market Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Polyglactin 910 Sutures (PGLA Sutures) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Polyglactin 910 Sutures (PGLA Sutures) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Polyglactin 910 Sutures (PGLA Sutures) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Polyglactin 910 Sutures (PGLA Sutures). Industry analysis & Market Report on Polyglactin 910 Sutures (PGLA Sutures) is a syndicated market report, published as Global (United States, European Union and China) Polyglactin 910 Sutures (PGLA Sutures) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Polyglactin 910 Sutures (PGLA Sutures) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.